Rockefeller Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$51.7M Buy
739,684
+121,483
+20% +$8.49M 0.11% 179
2025
Q1
$45.4M Buy
618,201
+220,984
+56% +$16.2M 0.11% 182
2024
Q4
$26M Buy
397,217
+236,882
+148% +$15.5M 0.07% 276
2024
Q3
$12.5M Buy
160,335
+2,739
+2% +$213K 0.03% 475
2024
Q2
$12.3M Buy
157,596
+3,869
+3% +$301K 0.03% 447
2024
Q1
$10.4M Sell
153,727
-20,244
-12% -$1.37M 0.03% 489
2023
Q4
$11.7M Sell
173,971
-1,209
-0.7% -$81.4K 0.04% 410
2023
Q3
$11.9M Buy
175,180
+2,075
+1% +$141K 0.05% 376
2023
Q2
$12.4M Buy
173,105
+24,675
+17% +$1.77M 0.05% 378
2023
Q1
$10.3M Sell
148,430
-4,190
-3% -$291K 0.04% 398
2022
Q4
$10.3M Buy
152,620
+806
+0.5% +$54.6K 0.05% 350
2022
Q3
$8.32M Sell
151,814
-12,465
-8% -$683K 0.04% 402
2022
Q2
$10.9M Buy
164,279
+11,897
+8% +$786K 0.06% 324
2022
Q1
$10.1M Buy
152,382
+66,944
+78% +$4.44M 0.05% 361
2021
Q4
$4.98M Sell
85,438
-11,165
-12% -$650K 0.02% 541
2021
Q3
$5.8M Buy
96,603
+44,351
+85% +$2.66M 0.03% 438
2021
Q2
$3.13M Buy
52,252
+28,713
+122% +$1.72M 0.02% 600
2021
Q1
$1.17M Sell
23,539
-2,390
-9% -$119K 0.01% 736
2020
Q4
$1.3M Buy
25,929
+7,319
+39% +$366K 0.01% 628
2020
Q3
$1.02M Sell
18,610
-907
-5% -$49.7K 0.01% 593
2020
Q2
$1.03M Buy
19,517
+1,888
+11% +$99.8K 0.01% 544
2020
Q1
$787K Sell
17,629
-12,148
-41% -$542K 0.01% 527
2019
Q4
$1.49M Buy
29,777
+4,212
+16% +$210K 0.02% 389
2019
Q3
$1.14M Buy
25,565
+5,302
+26% +$236K 0.02% 369
2019
Q2
$836K Sell
20,263
-29,475
-59% -$1.22M 0.01% 365
2019
Q1
$2.01M Buy
49,738
+48,963
+6,318% +$1.98M 0.03% 260
2018
Q4
$29K Buy
+775
New +$29K ﹤0.01% 577
2018
Q3
Sell
-910
Closed -$32K 755
2018
Q2
$32K Hold
910
﹤0.01% 485
2018
Q1
$32K Buy
+910
New +$32K ﹤0.01% 441